Study guide
16.2 Blood Product Administration
Certified Pediatric Hematology Oncology Nurse CPHON®
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Application, and Testing Logistics 1.3 Test Content Outline and Study Strategy
2 Care Continuum
2.1 Transition of Care: Primary Care and Levels of Care 2.2 End-of-Life Care 2.3 Health Promotion and Maintenance 2.4 Survivorship
3 Leukemias and Lymphomas
3.1 Acute Lymphoblastic Leukemia 3.2 Acute Myeloid Leukemia and Related Myeloid Disease 3.3 Hodgkin and Non-Hodgkin Lymphomas
4 CNS, Neuroblastoma, and Renal Tumors
4.1 Central Nervous System Tumors 4.2 Neuroblastoma 4.3 Wilms Tumor and Other Renal Tumors
5 Sarcomas and Other Solid Tumors
5.1 Osteosarcoma and Ewing Sarcoma 5.2 Rhabdomyosarcoma and Soft-Tissue Sarcomas 5.3 Retinoblastoma, Hepatoblastoma, and Germ Cell Tumors
6 Hematologic Disorders
6.1 Sickle Cell Disease 6.2 Thalassemia and Other Hemoglobinopathies 6.3 Hemophilia, von Willebrand Disease, and Coagulopathies 6.4 Immune Thrombocytopenia, Aplastic Anemia, and Bone Marrow Failure
7 Pathophysiology, Genetics, and Diagnostics
7.1 Anatomy, Physiology, and Pathophysiology Foundations 7.2 Genetics and Genomics 7.3 Diagnostic Testing, Staging, and Prognosis
8 Clinical Trials and Professional Performance
8.1 Clinical Trials and Informed Consent 8.2 Scope, Standards, and Regulatory Practice 8.3 Ethics and Patient-Family Education
9 Chemotherapy and Biotherapy
9.1 Chemotherapy Principles, Classes, and Pediatric Protocols 9.2 Safe Handling, Administration, and Vesicant Precautions 9.3 Biotherapy
10 Immunotherapy, Cellular Therapy, and Radiation
10.1 Immunotherapy 10.2 Cellular Therapies including CAR-T 10.3 Radiation Therapy, I-131-MIBG, and Proton Beam
11 HSCT, Surgery, Transfusion, and Coagulation Therapy
11.1 Hematopoietic Stem Cell Transplantation 11.2 Surgical Management 11.3 Blood Product Therapy, Leukapheresis, and Coagulation Therapy
12 Neurologic, Respiratory, and Cardiovascular Effects
12.1 Neurological Acute, Chronic, and Late Effects 12.2 Respiratory and Lymphatic Effects 12.3 Cardiovascular Effects
13 Gastrointestinal, Renal, Musculoskeletal, and Integumentary Effects
13.1 Gastrointestinal Effects 13.2 Renal and Genitourinary Effects 13.3 Musculoskeletal and Integumentary Effects
14 Endocrine, Hematologic, Immunologic, and Sensory Effects
14.1 Endocrine and Reproductive Effects 14.2 Hematological and Immunological Effects 14.3 Ophthalmological and Otological Effects
15 Pain, Sleep, Fatigue, and Mental Health
15.1 Pain Assessment and Management 15.2 Sleep Disturbance and Fatigue 15.3 Mental Health Effects
16 Supportive Care
16.1 Medical Devices: Venous Access, Pumps, Shunts, and Tubes 16.2 Blood Product Administration 16.3 Colony-Stimulating Factors 16.4 Interdisciplinary, Palliative, and Complementary Care
17 Infectious and Gastrointestinal Emergencies
17.1 Sepsis 17.2 Typhlitis 17.3 Pancreatitis and Bowel Obstruction
18 Metabolic Emergencies
18.1 Diabetes Insipidus and SIADH 18.2 Tumor Lysis Syndrome 18.3 Cytokine Release Syndrome
19 DIC, Hyperleukocytosis, and Sinusoidal Obstructive Syndrome
19.1 Disseminated Intravascular Coagulation and Hemorrhage 19.2 Hyperleukocytosis 19.3 Sinusoidal Obstructive Syndrome (Veno-Occlusive Disease)
20 Sickle Cell and Hemostasis Emergencies
20.1 Splenic Sequestration 20.2 Vaso-Occlusive Crisis 20.3 Stroke, Thrombosis, and Joint Bleed
21 Cardiopulmonary Emergencies
21.1 Acute Chest Syndrome 21.2 Respiratory Distress and Mediastinal Mass 21.3 Pleural Effusions and Arrhythmias
22 Neurologic and Infusion Emergencies
22.1 Increased Intracranial Pressure 22.2 Seizures and PRES 22.3 Spinal Cord Compression 22.4 Hypersensitivity Reactions and Extravasation
23 Family, Caregivers, and Social Integration
23.1 Effects of Acute and Chronic Illness on Patient and Family 23.2 Patient and Family/Caregiver Support 23.3 Integration into Family, School, Work, Camp, and Social Environment
24 Development, Grief, Culture, and Community Resources
24.1 Principles of Growth and Development 24.2 Grief and Bereavement 24.3 Culture, Sexuality and Gender, Socioeconomics, and Community Resources
16.2 Blood Product Administration
Key Takeaways Explain This Topic AI
Administration technique—not product choice—owns two-nurse independent verification, documented informed consent, baseline vital signs, and a 15-minute stay after the first drop.
Packed red cells run only with 0.9% sodium chloride; dextrose and lactated Ringer’s are incompatible. Use a blood filter and verify irradiated and leukoreduced attributes on the bag tag against the order.
Stop the transfusion for any suspected reaction; keep the line open with saline; emergency medications stay at the bedside.
Antihistamine or acetaminophen premedication is institutional, not a universal ONCC rule for every unit.
Watch volume overload in small children; infusion duration follows the product insert and hospital policy, not a single ONCC minute mandate.
Last updated: August 2026
TCO IV.C.2 is blood-product administration technique . Chapter 11.3 already chose the product: irradiated cellular units to prevent transfusion-associated graft-versus-host disease, leukoreduced and cytomegalovirus-safe units per blood-bank policy, platelets for bleeding or a procedure, red cells for symptomatic anemia, and the reaction names transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO). This section is the bedside clock: identifiers, consent, tubing, fluids, the first 15 minutes, and when to stop. A 3-year-old with acute myeloid leukemia (AML) whose red-cell bag is about to spike, a 12-kg toddler whose second unit is hanging too fast, and a 15-year-old who develops hives four minutes into platelets are administration items.
Two-nurse check, consent, vitals, and the first 15 minutes
Informed consent for transfusion is documented before the first drop except in a true life-threatening emergency when delay would kill; even then the team documents why consent could not wait. The consent conversation belongs to the prescriber; the nurse confirms it is on the chart and that the family can still state why the child is being transfused.
Two licensed nurses independently verify the child (name, medical record number, blood bank identification per policy) against the unit tag and the order: product type, ABO/Rh compatibility, donor unit number, expiration, and special attributes. “I already checked it in the medication room” is not an independent check. Mismatch of even one identifier stops the process before the spike.
Obtain a baseline set of vital signs immediately before starting. Stay with the child for the first 15 minutes after the infusion begins—the window when many acute hemolytic and anaphylactic reactions declare. Typical practice is a slow start, then a vital-sign set at about 15 minutes, then per policy for the remainder. Do not leave a toddler with a unit running to “catch up charting” during that first quarter hour. Teach the parent what to call out: new back or chest pain, itching, hives, chills, dyspnea, or a sense of doom in an older child.
Filter, compatible fluids, and the bag tag
Packed red cells run through a standard blood-administration set with a filter (commonly a 170–260 micron clot filter; follow the set in your hand). Do not spike red cells onto ordinary hypotonic tubing “because it was already primed.” Compatible fluid with red cells is 0.9% sodium chloride (normal saline) only. Dextrose can hemolyze red cells in the line. Lactated Ringer’s contains calcium that can clot citrated blood in the tubing. Other medications do not piggyback into the blood set. Platelets and plasma follow the same identity check; some products have product-specific sets—use what the blood bank and insert specify rather than improvising.
Irradiated and leukoreduced (and cytomegalovirus-safe, when ordered) attributes are verified on the bag tag against the order before the spike. A 2-year-old on AML induction whose unit is not labeled irradiated does not get that unit because the fridge was almost empty. Direct the unit back; hang the correctly modified product. Administration is the last chance to catch a product-choice error.
Stop for reaction; emergency drugs; premedication is not universal
Any suspected reaction: stop the transfusion , keep the intravenous line open with normal saline on new tubing if the set is contaminated with the unit, recheck the identity of child and bag, notify the provider and blood bank, and send the remaining product plus required specimens per policy. Do not finish “the last 40 mL.” Isolated hives may later restart a different unit with an antihistamine as ordered; anaphylaxis, hemolysis, TRALI, and TACO do not get a restart of the same bag. Full syndrome tables live in the product-choice chapter; the administration verb is stop .
Keep emergency medications at the bedside (or immediately reachable on the crash cart you have already located): oxygen, epinephrine for anaphylaxis, an antihistamine, and a prescribed diuretic for volume overload. Knowing the room number of the pharmacy is not bedside readiness.
Premedication with an antihistamine or acetaminophen is institutional and patient-specific , not a universal ONCC rule for every pediatric oncology transfusion. A child with prior urticaria may receive a protocol premed; a first-time, well-appearing transfusion does not automatically get acetaminophen that could mask a fever workup. Do not teach families that “we always premed so nothing can go wrong.”
Volume overload and infusion times without a fake ONCC minute
Small children have small vascular space. A 12-kg toddler given a large red-cell aliquot too fast can develop TACO : tachypnea, hypertension, rales, and hepatomegaly. Sit the child up, stop the unit, give the ordered diuretic, and consider splitting future units into aliquots with pauses. Infants and children with cardiac involvement (anthracyclines, mediastinal mass, chronic transfusion cardiomyopathy) are especially intolerant of a “wide-open” adult habit.
Infusion duration follows the product insert and hospital policy. Typical ranges—not ONCC-mandated single minutes—are that red cells are often completed in about 2 to 4 hours and are not left hanging beyond 4 hours from spike because of bacterial-growth risk; platelets and plasma usually infuse faster , often over about 30 to 60 minutes as the child and volume allow. Do not memorize one ONCC minute number. Do not stretch a red-cell unit over an entire night shift “so it is gentler” past the spiked-time limit. Do not bolt a full adult unit into a toddler because the next patient is waiting.
- Administration step Pediatric nursing product Trap
- Consent Documented before the first drop except true emergency Starting the unit while “consent is coming”
Two-nurse check Independent match of child, unit, ABO/Rh, attributes One nurse reading aloud while the other nods from the door
Baseline vitals and 15-minute stay Stay at the bedside; repeat vitals per policy Leaving during the highest-risk window
- Filter and fluid Blood set; NS only with RBCs Dextrose or lactated Ringer’s in the blood tubing
- Bag tag Irradiated / leukoreduced / CMV-safe as ordered Hanging an unmodified unit because it was close
- Reaction Stop; saline; notify; emergency drugs at bedside Finishing the bag to avoid waste
- Premed Institutional, not universal Automatic acetaminophen for every unit
Rate / volume Insert and policy; watch TACO in small children Inventing a single ONCC minute rule or wide-open adult rates
A 3-year-old whose two nurses matched an irradiated, leukoreduced red-cell unit to the armband, whose family signed consent, whose vitals were taken, whose nurse stayed 15 minutes, and whose tubing contained only normal saline is the CPHON administration product. A unit that was “probably fine” because the child “gets blood all the time” is not.